Sino Biopharmaceutical Limited (01177) said for the three months ended 31 March 2020, profit attributable to the owners of the parent was approximately RMB862.02 million, approximately 0.6% higher than that of the same period last year.
Basic earnings per share attributable to the owners of the parent were approximately RMB6.85 cent. The board of the company has declared the payment of a quarterly dividend of HK2 cents per share.
Revenue was approximately RMB6,221.87 million, an increase of approximately 0.2% over the same period last year.
全新節目《說說心理話》青少年不可以戀愛！？真實個案講述驚心動魄經歷► 即睇
